TESLA AND THE DIAMOND.
GROK:
Natural diamond values have depreciated significantly—typically in the range of 30–50% from their recent peaks (around 2021–2022)—largely due to the rapid increase in laboratory-grown diamond production. This has eroded the traditional scarcity premium that underpinned natural diamond pricing.
Key data on the decline (as of mid-to-late 2026)
- Diamond Standard Index (tracks investment-grade natural diamonds on Bloomberg): Hit an all-time low in early August 2026. It has fallen roughly 50% (inflation-adjusted) over the past four years.
- Wholesale prices (e.g., Rapaport RAPI and similar indices): Down approximately 30–40% from the 2021 peak, or 20–30% from the 2022 peak. Commercial-grade stones (0.5–1.5 carats, common engagement-ring qualities) have been hit hardest; larger, higher-quality, or rarer stones have held up better (often only 10–20% declines).
- Natural diamond production was deliberately cut by about 20% over the same period (from ~120 million carats/year to ~98 million) in an attempt to support prices, but this has not reversed the downward pressure.
Lab-grown diamonds are the main structural driver. They are chemically and optically identical to natural ones, now cost 80–90% less at retail/wholesale for equivalent quality, and have captured a large share of the engagement-ring market (often 40%+ in the US).
Production scaling (especially CVD methods in China and India) has driven lab-grown wholesale prices down 60–90% since ~2018–2020, turning them into a direct, much cheaper substitute and commoditizing diamonds overall.
Additional context
- Other contributing factors include the unwinding of pandemic-era demand spikes and softer luxury spending in key markets (e.g., China), but analysts consistently identify lab-grown supply growth as the dominant long-term force destroying the “natural = scarce = valuable” narrative.
- Resale/value retention: Natural diamonds still fare better (typically retaining 20–60% of retail on the secondary market, depending on quality and size) than lab-grown ones (often near 0–20%, or effectively near-zero as new production keeps getting cheaper). Neither is a strong pure investment.
- Recent months (2026) show some stabilization or minor rebounds in certain categories due to further production cuts, but the broader structural pressure remains.
In short, the surge in affordable lab-grown diamonds has caused natural diamond prices to lose roughly one-third to one-half of their peak value in recent years, with the biggest impact on everyday commercial stones. Prices for exceptional large or unique natural diamonds remain more resilient.
Natural diamonds vs. lab-grown is Tesla vs. the Chinese EV swarm.
Both started as scarce, high-status status symbols. Both got steamrolled by scaled, near-identical (or better-specced) alternatives that killed the premium overnight.
- Tesla was the natural diamond: The pioneer with the magic. Range anxiety solved, over-the-air updates, cult brand, Elon mystique. Buyers paid up for the “real thing”—scarcity of engineering excellence and first-mover aura. Margins were fat, valuation sky-high.
- Far East EVs (BYD, NIO, XPeng, Zeekr, MG, etc.) are the lab-grown flood: Chemically different but functionally ruthless. Same (or better) battery tech, more screens, more ADAS toys, longer warranties, and prices that undercut Tesla by 30-50%+ while packing every bell and whistle. Production scaled in China like CVD reactors—cost curves collapsed, supply exploded.
Result? The same structural gut-punch:
- Scarcity premium vaporized. Natural diamonds lost 30-50% of peak value; Tesla’s once-untouchable pricing power and stock premium got hammered as volume shifted to cheaper, feature-stuffed alternatives.
- Consumers stopped caring about “origin.” Most engagement-ring buyers now shrug at lab-grown; most EV shoppers outside the tariff walls just want the biggest battery and the lowest monthly payment.
- The old guard cuts production (De Beers/Alrosa vs. Tesla’s occasional volume discipline) and still can’t stop the price slide.
The difference?
Diamonds are perfect substitutes—lab stones are optically and chemically identical.
EVs aren’t:
Tesla still owns the software stack, Supercharger network, and brand halo in key markets.
But the analogy holds hard on the economics:
when the Far East can print high-spec EVs at scale the way China/India print lab diamonds, the “prized” original stops being a store of value and starts being just another car (or just another rock).
Punchline:
Both industries learned the hard way that when technology turns rarity into a factory process, prestige becomes a temporary markup—and the market doesn’t care about your origin story once the cheaper version has all the sparkle (or the 800-volt architecture).

Comments
Post a Comment
GROK'S INPUT ON TESLA